XML 39 R28.htm IDEA: XBRL DOCUMENT v3.21.1
9. FAIR VALUE DISCLOSURES (Tables)
 3 Months Ended
Mar. 31, 2021
Fair Value Disclosures [Abstract]  
Schedule of financial assets and liabilities at fair value

Financial assets and liabilities measured at fair value on a recurring basis were as follows:

  

   Level 1   Level 2   Level 3 
         (In thousands)      
Assets as of March 31, 2021:               
Equity securities at fair value  $122,469   $57,851   $– 
Total recurring fair value measurements as of March 31, 2021  $122,469   $57,851   $– 
                
Assets as of December 31, 2020:               
Equity securities at fair value  $109,103   $–   $– 
Investment at fair value - warrants   –    2,752    – 
Total recurring fair value measurements as of December 31, 2020  $109,103   $2,752   $– 
                
Liabilities as of March 31, 2021:               
Series A warrants  $–   $–   $18,243 
Series B warrants   –    –    225,956 
Embedded derivative liabilities   –    –    40,419 
Total liabilities as of March 31, 2021  $–   $–   $284,618 
                
Liabilities as of December 31, 2020:               
Series A warrants  $–   $6,640   $– 
Series B warrants   –    –    52,341 
Embedded derivative liabilities   –    –    26,728 
Total liabilities as of December 31, 2020  $–   $6,640   $79,069 

 
Schedule of changes in fair value Level 3 liabilities

The following table sets forth a summary of the changes in the estimated fair value of the Company’s Level 3 liabilities, which are measured at fair value on a recurring basis:

 

   Series A Warrants Liability   Series A Preferred Stock Embedded Derivative Liability   Series B Warrants Liability 
       (In thousands)     
Opening balance as of January 1, 2021  $–   $26,728   $52,341 
Transfers into Level 3   6,640    –    – 
Remeasurement to fair value   11,603    13,691    173,615 
Balance as of March 31, 2021  $18,243   $40,419   $225,956